Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg‐proline‐interferon alpha‐2bNicole C.C. Them, Róbert Královics, Ernst Schloegl et al.|American Journal of Hematology|2014Cited by 54
Acquired resistance to interferon alpha therapy associated with homozygous MPL‐W515L mutation and chromosome 20q deletion in primary myelofibrosisVeronika Buxhofer‐Ausch, Róbert Královics, Heinz Gisslinger et al.|European Journal Of Haematology|2008Cited by 11
Analysis Of Molecular Responses and Chromosomal Aberrations In Patients With Polycythemia Vera Treated With Peg-Proline-Interferon Alpha-2b (AOP2014/P1101) In The Peginvera StudyNicole C.C. Them, Róbert Královics, Heinz Gisslinger et al.|Blood|2013Cited by 3
Calreticulin Mutation Status Predicts Improved Disease Outcome in Prefibrotic Primary Myelofibrosis but Not in WHO-Defined Essential ThrombocythemiaHeinz Gisslinger, Róbert Královics, Jüergen Thiele et al.|Blood|2014Cited by 1